Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06700460 · ClinicalTrials.gov registry record · NA

Measuring Outcomes of LASIK and EVO-ICL in Matched Populations

A NA study of Myopia, sponsored by Vance Thompson Vision.

Recruiting
Registry status
NA
Development phase
56
Enrollment target
5
Study locations

NCT06700460 is a NA study of Myopia that is actively recruiting participants, run by Vance Thompson Vision. The registered enrollment target is 56 participants, below the 267-participant average among 90 other Myopia trials with a reported enrollment target (79% lower). The trial reports 5 study locations across 5 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06700460, a NA study of Myopia, is actively recruiting participants, sponsored by Vance Thompson Vision.

RECRUITING
Registry status
NA
Development phase
56 participants
Enrollment target
5
Study locations

Study Summary

Evaluating outcomes after bilateral implantation of ICLs or bilateral LASIK as treatment options for the correction or reduction of myopia with or without astigmatism.

Conditions Studied

Interventions

  • DEVICE Laser-assisted in Situ Keratomileusis
  • DEVICE Implantable Collamer Lens placement

Study Locations (5)

Nebraska

  • Kugler Vision - Omaha

Ohio

  • Cleveland Eye Clinic - Cleveland

South Carolina

  • Carolina Eyecare Physicians - Mt. Pleasant

South Dakota

  • Vance Thompson Vision Clinic - Sioux Falls

Texas

  • Slade & Baker Vision - Houston

Trial Details

FieldValue
Enrollment Target 56 participants
Start Date 2024-11-27
Est. Completion 2025-04-01
Phase NA

Sponsor

Vance Thompson Vision

14 total trials

What the Registry Record Tells You About NCT06700460

The ClinicalTrials.gov registry entry for NCT06700460 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 56 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 267-participant average among 90 other Myopia trials with a reported enrollment target (79% lower). The listed sponsor is Vance Thompson Vision, which has 14 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Myopia appearing as the primary indexed condition, and to 2 interventions - of which Laser-assisted in Situ Keratomileusis is the first listed.

NCT06700460 reports 5 study locations spanning 5 distinct geographic areas - top geographies include Nebraska, Ohio, South Carolina.

Frequently Asked Questions

What is clinical trial NCT06700460 about?

NCT06700460 is a clinical study titled "Measuring Outcomes of LASIK and EVO-ICL in Matched Populations". Evaluating outcomes after bilateral implantation of ICLs or bilateral LASIK as treatment options for the correction or reduction of myopia with or without astigmatism.

What is the current status of trial NCT06700460?

This trial is currently recruiting. It is a NA study. The enrollment target is 56 participants. The study started on 2024-11-27. Estimated completion is 2025-04-01.

What conditions does trial NCT06700460 study?

This clinical trial studies the following conditions: Myopia.

What interventions are being tested in trial NCT06700460?

The interventions under investigation include: Laser-assisted in Situ Keratomileusis (DEVICE), Implantable Collamer Lens placement (DEVICE).

Who is sponsoring clinical trial NCT06700460?

This trial is sponsored by Vance Thompson Vision, which has 14 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06700460 being conducted?

This trial has 5 study locations across Nebraska, Ohio, South Carolina, South Dakota, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Myopia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.